breast cancer and glp 1 drugs GLP-1 cut risk by 30%? Not so fast GLP-1 may improve survival, reduce

A recent case-control study of 1,961 new GLP-1RA patients showed that use of GLP-1RAs significantly reduced the risk of glaucoma, with a hazard ratio of 0.56 [94]

Edwards CM, Stanley SA, Davis R, et al

Clinical decisions should be individualized based on patient preferences, comorbidities, medication regimens, and treatment goals, with ongoing medical supervision to monitor safety and efficacy

In this article, we will explore the different GLP-1 weight loss options available on the market and determine what sets Semaglutide apart

GLP-1 receptor agonists are a type of medication that can offer a range of positive health outcomes

Both Eli Lilly and Novo Nordisk have publicly acknowledged backorders and rationing of products like Mounjaro and Ozempic due to unprecedented demand